This course will present, in one place, the regulations and guidelines that apply to early phase products. In some cases these will not be regulations, but needs that, if met, will increase the efficiency of activities as a product proceeds through the development process. The course will present these items in the order of product development from the point of R & D activities to the completion of Phase 2 clinical trials. Why should you attend: Any pharmaceutical worker who must deal with products both in early and latter phases of development should attend this course in order to be aware

Date : 13th November 2017 to 14th November 2017

Place : United States, Taipei, taiwan

Website :http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901321SEMINAR?allconferencealerts-November-2017-SEO

Contact Person:Eevnt Manager

Description:

This course will present, in one place, the regulations and guidelines that apply to early phase products. In some cases these will not be regulations, but needs that, if met, will increase the efficiency of activities as a product proceeds through the development process. The course will present these items in the order of product development from the point of R & D activities to the completion of Phase 2 clinical trials. Why should you attend: Any pharmaceutical worker who must deal with products both in early and latter phases of development should attend this course in order to be aware

This course will present, in one place, the regulations and guidelines that apply to early phase products. In some cases these will not be regulations, but needs that, if met, will increase the efficiency of activities as a product proceeds through the development process. The course will present these items in the order of product development from the point of R & D activities to the completion of Phase 2 clinical trials. Why should you attend: Any pharmaceutical worker who must deal with products both in early and latter phases of development should attend this course in order to be aware will be held in Taipei, taiwan,United States on date 2017-11-14

---

Deadline for abstracts/proposals : 12th November 2017

Keynote Speakers : Dr. Steven Kuwahara Founder & Principal, GXP Biotechnology, LLC Dr. Steven Kuwahara, Ph.D. is the Founder and Principal of GXP BioTechnology LLC, a consulting firm that works in the areas covered by the GLP and GMP of drugs, biologics, and nutraceuticals. Steve has over 30 years of experience in supervising quality control laboratories, including an animal testing facility, and in performing GLP and GMP audits of internal and external testing laboratories. Steve has participated in the d

Conference Highlights :Directors, Managers, Supervisors, and lead workers in Regulatory Affairs, Quality Assurance and Quality Control Workers who will prepare GMP documents for early phase products as well as those who will review these documents Regulatory affairs workers who will need to deal with submissions covering early phase products

Venue :Taipei, Taiwan

Check the event website for more details.